|1.44||+0.03 / +2.13%|
Data as of 4:00pm ET
|1.44||0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for LifeVantage Corp have a median target of 2.10, with a high estimate of 2.10 and a low estimate of 2.10. The median estimate represents a +45.83% increase from the last price of 1.44.
The current consensus among 2 polled investment analysts is to Buy stock in LifeVantage Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.